IMAX Corporation’s (IMAX - Free Report) subsidiary IMAX China recently stated that Viacom owned Paramount Pictures' Bumblebee collected $6.1 million from 587 IMAX theaters this weekend. IMAX noted that this is one of its best January performances.
Transformers spinoff Bumblebee became the highest grossing film at the Chinese box office and raked in about $59 million in its opening weekend. The film also derailed Aquaman’s four-week dominance as the top grosser globally by collecting $82.7 million in 63 foreign markets.
Other Hollywood titles that boosted IMAX China’s box office performance include Aquaman, a production of AT&T’s (T - Free Report) Warner Bros., and Sony’s Venom. Solid collection from these movies led to 40% year-over-year over growth at IMAX China box office from Nov 3, 2018 to Jan 3, 2019.
Moreover, Disney’s (DIS - Free Report) Ralph Breaks the Internet and Sony’s Spider-Man: Into the Spider-Verse did well at the Chinese box office, per Variety.
IMAX also noted that Aquaman was the highest selling IMAX title in China in fourth-quarter 2018 and drove December box office collections to $27.23 million.
Notably, Aquaman pulled in $4.1 million in its fifth week and garnered a total of $283 million from China. Additionally, the film, which became the second highest-grossing superhero movie ever this week in China leads in terms of collections across markets. Moreover, the film is the highest-grossing movie ever in Asia with global collection of $940 million.
IMAX Corporation Revenue (TTM)
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
IMAX Corporation’s (IMAX - Free Report) subsidiary IMAX China recently stated that Viacom owned Paramount Pictures' Bumblebee collected $6.1 million from 587 IMAX theaters this weekend. IMAX noted that this is one of its best January performances.
Transformers spinoff Bumblebee became the highest grossing film at the Chinese box office and raked in about $59 million in its opening weekend. The film also derailed Aquaman’s four-week dominance as the top grosser globally by collecting $82.7 million in 63 foreign markets.
Other Hollywood titles that boosted IMAX China’s box office performance include Aquaman, a production of AT&T’s (T - Free Report) Warner Bros., and Sony’s Venom. Solid collection from these movies led to 40% year-over-year over growth at IMAX China box office from Nov 3, 2018 to Jan 3, 2019.
Moreover, Disney’s (DIS - Free Report) Ralph Breaks the Internet and Sony’s Spider-Man: Into the Spider-Verse did well at the Chinese box office, per Variety.
IMAX also noted that Aquaman was the highest selling IMAX title in China in fourth-quarter 2018 and drove December box office collections to $27.23 million.
Notably, Aquaman pulled in $4.1 million in its fifth week and garnered a total of $283 million from China. Additionally, the film, which became the second highest-grossing superhero movie ever this week in China leads in terms of collections across markets. Moreover, the film is the highest-grossing movie ever in Asia with global collection of $940 million.
IMAX Corporation Revenue (TTM)
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on T - FREE
Get the latest research report on DIS - FREE
Get the latest research report on IMAX - FREE